Table A8.
Sample ID | ESBL | Ertapenem | Imipenem | Meropenem | Gentamicin | Ciprofloxacin | Moxifloxacin | Tigecycline | Trimethoprim/Sulfamethoxazole | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | MIC | Interpretation | ||
41 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≥16 | R | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
49 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
68 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
117 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
152 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | 2 | S | 1 | R | 2 | R | ≤0.5 | S | ≥320 | R |
176 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
221 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
222 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≤0.25 | S | ≤0.25 | S | ≤0.5 | S | ≥320 | R |
225 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | 0.5 | I | 1 | R | ≤0.5 | S | ≥320 | R |
245 | positive | ≤0.5 | S | 0.5 | S | ≤0.25 | S | ≥16 | R | ≥4 | R | ≥8 | R | ≤0.5 | S | ≥320 | R |
270 | positive | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | ≥4 | R | ≥8 | R | ≤0.5 | S | ≤20 | S |
299 | negative | ≤0.5 | S | ≤0.25 | S | ≤0.25 | S | ≤1 | S | 0.5 | I | 2 | R | ≤0.5 | S | ≥320 | R |